证券代码：688310 证券简称：迈得医疗 公告编号：2026-005 迈得医疗工业设备股份有限公司 关于向控股子公司提供财务资助暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 迈得医疗工业设备股份有限公司（以下简称"公司"）拟以自有资金向控 股子公司浙江迈得顺隐形眼镜有限公司（以下简称"迈得顺"）提供财务资助，资 助金额合计不超过人民币 10,000 万元，资助期限为自公司股东会审议通过之日 起 3 年内，借款利率参照合同签订之日的前 1 工作日全国银行间同业拆借中心受 权公布的一年期贷款市场报价利率（LPR），利息按照借款对象实际借款占用天 数计算，上述额度基于实际业务经营需求提取借款，在有效期限内可以循环滚动 使用。迈得顺的少数股东未按出资比例提供同等条件的财务资助，作为迈得顺少 数股东之一的林军华先生系公司实际控制人、董事长、总经理，陈万顺先生系持 股公司 5%以上股东，两者同时为本次财务资助提供连带责任保证（具体以签署 的相关协议为准）。依据《上海证券交易所科创板股票上市规则》（以下 ...

证券代码：688310 证券简称：迈得医疗 公告编号：2026-006 迈得医疗工业设备股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东会类型和届次 网络投票起止时间：自2026 年 2 月 9 日 召开日期时间：2026 年 2 月 9 日 13 点 30 分 2026年第一次临时股东会 至2026 年 2 月 9 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过互联 股东会召开日期：2026年2月9日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 （二） 股东会召集人：董事会 （三） 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 （四） 现场会议召开的日期、时间和地点 网投票平台的投票时间为股东会召开当日的 9:15-15:00。 召开地点：浙江省 ...

第五届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688310 证券简称：迈得医疗 公告编号：2026-004 迈得医疗工业设备股份有限公司 一、董事会会议召开情况 迈得医疗工业设备股份有限公司（以下简称"公司"）第五届董事会第九次会 议（以下简称"本次会议"）于 2026 年 1 月 22 日以现场加通讯的方式在公司会议 室召开。本次会议的通知已于 2026 年 1 月 16 日以电子邮件方式送达全体董事。 本次会议由董事长林军华先生主持，应出席会议董事 8 人，实际出席会议董事 8 人。本次会议的召开符合《中华人民共和国公司法》等法律、行政法规以及《迈 得医疗工业设备股份有限公司章程》的相关规定。 二、董事会会议审议情况 经与会董事审议表决，通过了如下议案： (一)审议通过了《关于向控股子公司提供财务资助暨关联交易的议案》 经审议，董事会同意公司在不影响自身正常业务开展及资金使用的前提下， 以自有资金向迈得顺提供总额不超过人民币 1 亿元的财务资助，资助期限为自公 司股东会审议通 ...

Core Viewpoint - The stock of Maide Medical (688310) has shown a slight increase, with a closing price of 16.51 yuan on January 21, 2026, reflecting a 1.54% rise, while the company faces mixed capital flow dynamics [1][2]. Group 1: Stock Performance - As of January 21, 2026, Maide Medical's stock closed at 16.51 yuan, up by 1.54% with a turnover rate of 1.49% and a trading volume of 24,700 hands, resulting in a transaction amount of 40.74 million yuan [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with a net outflow of 363.54 thousand yuan on January 21, 2026, and a net inflow of 207.68 thousand yuan from retail investors [2]. Group 2: Financial Metrics and Industry Comparison - Maide Medical's total market capitalization is 2.744 billion yuan, with a net asset value of 840 million yuan and a net profit of 8.8367 million yuan, ranking 231st, 204th, and 190th respectively in the specialized equipment industry [3]. - The company reported a net profit margin of -2.43% and a return on equity (ROE) of 1.1%, which are below the industry averages of 4.37% and 2.68% respectively [3]. - For the first three quarters of 2025, Maide Medical's main revenue reached 225 million yuan, a year-on-year increase of 2.31%, while the net profit increased by 15.82% to 8.8367 million yuan [3].

Core Viewpoint - The company Maide Medical (688310) has shown a modest increase in stock price and a mixed performance in financial metrics, indicating potential growth opportunities alongside some challenges in profitability [1][2]. Group 1: Stock Performance - As of January 20, 2026, Maide Medical's stock closed at 16.26 yuan, with a slight increase of 0.06% [1]. - The trading volume was 34,600 hands, with a total transaction value of 56.879 million yuan [1]. - The net outflow of main funds was 5.9071 million yuan, accounting for 10.39% of the total transaction value, while retail investors saw a net inflow of 5.4365 million yuan, representing 9.56% of the total [1]. Group 2: Financial Performance - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, reflecting a year-on-year increase of 2.31% [2]. - The net profit attributable to shareholders was 8.8367 million yuan, up 15.82% year-on-year, while the non-recurring net profit decreased significantly by 526.58% to -1.2785 million yuan [2]. - In Q3 2025 alone, the company achieved a main revenue of 83.643 million yuan, a substantial increase of 54.38% year-on-year, and a net profit of 2.7916 million yuan, which is a remarkable rise of 224.07% [2]. - The company's gross margin stood at 40.19%, with a debt ratio of 29.86% [2].

证券日报网讯1月20日，迈得医疗在互动平台回答投资者提问时表示，公司2024年境外收入占当年营业 收入的比例为6.41%，具体内容请查阅公司相关公告。关于2025年境外市场表现，敬请关注公司2025年 年度报告。在业务模式方面，公司的业务拓展以直销方式或者通过第三方贸易商、代理商为主。 ...

Group 1 - The core stock price of Maide Medical (688310) closed at 16.15 yuan on January 16, 2026, with an increase of 1.57% and a turnover rate of 1.6% [1] - The trading volume was 26,500 shares, with a total transaction amount of 42.5062 million yuan [1] - On January 16, the net inflow of main funds was 3.6203 million yuan, indicating a positive short-term attitude from main investors [2] Group 2 - Maide Medical announced that from December 30, 2025, to January 14, 2026, it repurchased a total of 1,000,061 shares, accounting for 0.6017% of the total share capital, with a total expenditure of 15,918,630.44 yuan [1] - The repurchase price ranged from 15.69 yuan to 16.20 yuan per share, and the total expected repurchase amount is between 20 million yuan and 40 million yuan [1] - As of January 14, 2026, the cumulative repurchased shares reached 3,592,636, representing 2.1614% of the total share capital, indicating that the repurchase process is more than halfway complete [2]

Group 1 - The core viewpoint of the news is that Maide Medical (688310) has shown positive financial performance in recent quarters, with significant growth in revenue and net profit [2] - As of January 16, 2026, Maide Medical's stock closed at 16.15 yuan, reflecting a 1.57% increase, with a trading volume of 26,500 lots and a total transaction amount of 42.51 million yuan [1] - The company reported a main revenue of 225 million yuan for the first three quarters of 2025, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.84 million yuan, up 15.82% year-on-year [2] Group 2 - In Q3 2025, Maide Medical achieved a quarterly main revenue of 83.64 million yuan, representing a year-on-year increase of 54.38%, and a net profit of 2.79 million yuan, which is a 224.07% increase year-on-year [2] - The company's debt ratio stands at 29.86%, with an investment income of 167,600 yuan and financial expenses of -523,600 yuan, indicating a healthy financial position [2] - Maide Medical specializes in the research, production, sales, and service of medical consumables and intelligent equipment, integrating technology in medical device processes, automation, and software to provide comprehensive solutions for medical consumable manufacturers [2]

证券日报网讯1月15日，迈得医疗发布公告称，截至2026年1月14日，本次公司通过集中竞价交易方式累 计回购公司股份1，000，061股，占公司总股本166，219，690股的比例为0.6017%。 ...

Group 1 - The core viewpoint of the news is that Maide Medical (688310) has shown mixed financial performance in recent reports, with a slight increase in revenue but a significant decline in non-recurring net profit [2] - As of January 15, 2026, Maide Medical's stock closed at 15.9 yuan, down 0.31%, with a turnover rate of 1.78% and a trading volume of 29,600 hands, resulting in a transaction amount of 46.9974 million yuan [1] - The net outflow of main funds on January 15 was 234.64 thousand yuan, accounting for 4.99% of the total transaction amount, while retail investors saw a net inflow of 340.87 thousand yuan, representing 7.25% of the total transaction amount [1] Group 2 - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.8367 million yuan, up 15.82% year-on-year [2] - In the third quarter of 2025, the company achieved a single-quarter main revenue of 83.643 million yuan, a year-on-year increase of 54.38%, and a net profit attributable to shareholders of 2.7916 million yuan, up 224.07% year-on-year [2] - The company's debt ratio stands at 29.86%, with an investment income of 167.6 thousand yuan and financial expenses of -523.6 thousand yuan, while the gross profit margin is 40.19% [2]